Belleville S., Gauthier S., Lepage E., Kergoat M. J., Gilbert B. (2014). Predicting decline in mild cognitive impairment: a prospective cognitive study, Neuropsychology, 28(4), 643-52. En savoir plus.

Dubois B., Feldman H. H., Jacova C., Hampel H., Molinuevo J. L., Blennow K., DeKosky S. T., Gauthier S., Selkoe D., Bateman R., Cappa S., Crutch S., Engelborghs S., Frisoni G. B., Fox N. C., Galasko D., Habert M. O., Jicha G. A., Nordberg A., Pasquier F., Rabinovici G., Robert P., Rowe C., Salloway S., Sarazin M., Epelbaum S., de Souza L. C., Vellas B., Visser P. J., Schneider L., Stern Y., Scheltens P., Cummings J. L. (2014). Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, 13(6), 614-29. En savoir plus.

Gauthier S., Leuzy A., Rosa-Neto P. (2014). How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease?, Neurodegener Dis, 13(2-3), 197-9. En savoir plus.

Hye A., Riddoch-Contreras J., Baird A. L., Ashton N. J., Bazenet C., Leung R., Westman E., Simmons A., Dobson R., Sattlecker M., Lupton M., Lunnon K., Keohane A., Ward M., Pike I., Zucht H. D., Pepin D., Zheng W., Tunnicliffe A., Richardson J., Gauthier S., Soininen H., Kloszewska I., Mecocci P., Tsolaki M., Vellas B., Lovestone S. (2014). Plasma proteins predict conversion to dementia from prodromal disease, Alzheimers Dement. En savoir plus.

Jia J., Zhou A., Wei C., Jia X., Wang F., Li F., Wu X., Mok V., Gauthier S., Tang M., Chu L., Zhou Y., Zhou C., Cui Y., Wang Q., Wang W., Yin P., Hu N., Zuo X., Song H., Qin W., Wu L., Li D., Jia L., Song J., Han Y., Xing Y., Yang P., Li Y., Qiao Y., Tang Y., Lv J., Dong X. (2014). The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese, Alzheimers Dement, 10(4), 439-47. En savoir plus.

Leuzy A., Zimmer E. R., Bhat V., Rosa-Neto P., Gauthier S. (2014). Imaging biomarkers for amyloid: a new generation of probes and what lies ahead, Int Psychogeriatr, 26(5), 703-7. En savoir plus.

Leuzy A., Zimmer E. R., Heurling K., Rosa-Neto P., Gauthier S. (2014). Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues, Amyloid, 21(3), 143-8. En savoir plus.

Petersen R. C., Caracciolo B., Brayne C., Gauthier S., Jelic V., Fratiglioni L. (2014). Mild cognitive impairment: a concept in evolution, J Intern Med, 275(3), 214-28. En savoir plus.

Poirier J., Gauthier S. (2014). Alzheimer’s disease. The Complete Introduction, .

Robert P. H., Konig A., Amieva H., Andrieu S., Bremond F., Bullock R., Ceccaldi M., Dubois B., Gauthier S., Kenigsberg P. A., Nave S., Orgogozo J. M., Piano J., Benoit M., Touchon J., Vellas B., Yesavage J., Manera V. (2014). Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty, Front Aging Neurosci, 6, 54. En savoir plus.

Schoemaker D., Gauthier S., Pruessner J. (2014). Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer's disease: a literature review, Neuropsychol Rev, 24(3), 313-31. En savoir plus.

Tourian L., Margolese H. C., Gauthier S. (2014). Donepezil-Associated Mania in 2 Patients who Were Using Donepezil Without a Prescription, J Clin Psychopharmacol. En savoir plus.

Vellas B., Sampaio C., Bateman R., Boxer A., Carrillo MC., Cummings J., Dubois B., Hampel H., Katz R., Khachaturian Z., Gauthier S., Johnson K., Karlawish J., Mintun M., Petersen R., Rafii M., Robert P., Schneider LS., Siemers E., Sperling R., Tariot P., Touchon J., Weiner M., Andrieu S., Aisen P., Task Force Members (2014). E.U./U.S. CTAD Task Force on Alzheimer's Trial Populations, J Prev Alz Dis, 1(2), 110-116.

Wimo A., Ballard C., Brayne C., Gauthier S., Handels R., Jones R. W., Jonsson L., Khachaturian A. S., Kramberger M. (2014). Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria, J Intern Med, 275(3), 304-16. En savoir plus.

Wu L., Soder R. B., Schoemaker D., Carbonnell F., Sziklas V., Rowley J., Mohades S., Fonov V., Bellec P., Dagher A., Shmuel A., Jia J., Gauthier S., Rosa-Neto P. (2014). Resting state executive control network adaptations in amnestic mild cognitive impairment, J Alzheimers Dis, 40(4), 993-1004. En savoir plus.

Zimmer E. R., Leuzy A., Benedet A. L., Breitner J., Gauthier S., Rosa-Neto P. (2014). Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging, J Neuroinflammation, 11, 120. En savoir plus.

Zimmer E. R., Leuzy A., Bhat V., Gauthier S., Rosa-Neto P. (2014). In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals, Transl Neurodegener, 3(1), 6. En savoir plus.

Zimmer E. R., Leuzy A., Gauthier S., Rosa-Neto P. (2014). Developments in Tau PET Imaging, Can J Neurol Sci, 41(5), 547-53. En savoir plus.

Zimmer E. R., Parent M. J., Cuello A. C., Gauthier S., Rosa-Neto P. (2014). MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research, Trends Neurosci. En savoir plus.